Skip to main content
. 2023 Apr 13;41(3):402–410. doi: 10.1007/s10637-023-01339-6

Fig. 2.

Fig. 2

Mean (± standard deviation) unbound brigatinib plasma concentration-time profiles from a 0 to 24 hours postdose (linear scale) and b 0 to 192 hours postdose (log-linear scale)